Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 367

Results For "US"

7348 News Found

Lupin receives approval from U.S. FDA for Varenicline Tablets
News | December 07, 2023

Lupin receives approval from U.S. FDA for Varenicline Tablets

Varenicline Tablets, 0.5 mg and 1 mg are indicated for use as an aid to smoking cessation treatment.


Akums acquires new facility in Baddi to enhance tablet manufacturing capacity
News | December 07, 2023

Akums acquires new facility in Baddi to enhance tablet manufacturing capacity

his marks the 12th formulation facility under Akums, and the second in Baddi, a strategic move with an aim to enhance Akums’ manufacturing capabilities.


Sun Pharmaceutical inks licensing agreement with Aclaris Therapeutics
News | December 06, 2023

Sun Pharmaceutical inks licensing agreement with Aclaris Therapeutics

The agreement includes an upfront payment of US$15 million, regulatory and commercial milestones, and royalties


Briefs: Shelter Pharma and GMM Pfaudler
News | December 06, 2023

Briefs: Shelter Pharma and GMM Pfaudler

GMM Pfaudler US completes acquisition of MixPro


Mankind Pharma's PetStar ties up with Ranbir Kapoor and Neetu Kapoor for new campaign
News | December 06, 2023

Mankind Pharma's PetStar ties up with Ranbir Kapoor and Neetu Kapoor for new campaign

The esteemed duo perfectly embody the brand's core values of family, love, and the special bond we share with our pets


Cupid acquires land parcel near Mumbai
News | December 05, 2023

Cupid acquires land parcel near Mumbai

The acquisition will enable Cupid Limited to amplify its production capacity by 1.5 times the existing output


Pradeep Chakravarty joins Alembic Pharmaceuticals as Head - Global Quality
People | December 05, 2023

Pradeep Chakravarty joins Alembic Pharmaceuticals as Head - Global Quality

Prior to joining Alembic, he was working with Lupin Limited for more than 11 years


AstraZeneca discontinues Phase III trials of Stabilizer-CKD and Dialize-Outcomes
News | December 05, 2023

AstraZeneca discontinues Phase III trials of Stabilizer-CKD and Dialize-Outcomes

STABILIZE-CKD and DIALIZE-Outcomes trials are part of the CRYSTALIZE evidence programme


PerkinElmer acquires Covaris to create an innovation-led diagnostics platform
News | December 05, 2023

PerkinElmer acquires Covaris to create an innovation-led diagnostics platform

Covaris is a global leader in the development and deployment of end-to-end solutions for high-throughput genomic and proteomic analysis


Evonik launches Ecohance Soft Baobab oil for natural cosmetic formulations
Sustainability | December 04, 2023

Evonik launches Ecohance Soft Baobab oil for natural cosmetic formulations

High-quality baobab oil sourced in collaboration with UNCCD and the Great Green Wall Initiative